TAG supports opposition of Sanofi TB drug patents in India
09-12-2019
US considers shortening marketing exclusivity to push forward USMCA
03-12-2019
J&J invests $500m into global HIV and TB treatment
10-10-2019
Kateryna Kon / Shutterstock.com
The Global Drug Facility, which provides tuberculosis (TB) treatments to those in need in 150 countries, has listed a new drug to its product catalogue.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Global Drug Facility, tuberculosis, pretomanid, US Food and Drug Administration, India, Mylan, generics
